This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005:16 Suppl 8:viii20-viii29.

doi: 10.1093/annonc/mdi963.

Clinical trials in ovarian carcinoma: study methodology

J B Vermorken¹, M K B Parmar, M F Brady, E A Eisenhauer, T Hogberg, R F Ozols, J Rochon, G J S Rustin, S Sagae, R H M Verheijen; Gynecologic Cancer Intergroup; EORTC; MRC/NCRI; GOG; NCIC-CTG; NSGO; AGO-OVAR; JGOG

Affiliations

PMID: 16239233
DOI: 10.1093/annonc/mdi963

Free article

Clinical trials in ovarian carcinoma: study methodology

J B Vermorken et al. Ann Oncol. 2005.

Free article

. 2005:16 Suppl 8:viii20-viii29.

doi: 10.1093/annonc/mdi963.

Authors

J B Vermorken¹, M K B Parmar, M F Brady, E A Eisenhauer, T Hogberg, R F Ozols, J Rochon, G J S Rustin, S Sagae, R H M Verheijen; Gynecologic Cancer Intergroup; EORTC; MRC/NCRI; GOG; NCIC-CTG; NSGO; AGO-OVAR; JGOG

Affiliation

¹ Department of Oncology, University Hospital Antwerp, Edegem, Belgium. Jan.b.Vermorken@uza.be

PMID: 16239233
DOI: 10.1093/annonc/mdi963

No abstract available

PubMed Disclaimer

Similar articles

Integration of new or experimental treatment options and new approaches to clinical trials.
Quinn M, Pfisterer J, Avall-Lundqvist E, Bookman M, Bowtell D, Casado A, Cervantes A, Grenman S, Harper P, Oza A, Pecorelli S, Pujade-Lauraine E, Trimble E, Vasey P, Wagner U; ANZGOG; AGO-OVAR; NSGO; GOG; EORTC; GEICO; MRC/NCRI; NCIC-CTG; IGCS; GINECO; NCI-US; SGCTG. Quinn M, et al. Ann Oncol. 2005;16 Suppl 8:viii30-viii35. doi: 10.1093/annonc/mdi964. Ann Oncol. 2005. PMID: 16239234 No abstract available.
Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens.
Thigpen T, Stuart G, du Bois A, Friedlander M, Fujiwara K, Guastalla JP, Kaye S, Kitchener H, Kristensen G, Mannel R, Meier W, Miller B, Poveda A, Provencher D, Stehman F, Vergote I; Gynecologic Cancer Intergroup; GOG; NCIC-CTG; AGO-OVAR; ANZGOG; JGOG; GINECO; SGCTG; MRC/NCRI; NSGO; RTOG; GEICO; EORTC. Thigpen T, et al. Ann Oncol. 2005;16 Suppl 8:viii13-viii19. doi: 10.1093/annonc/mdi962. Ann Oncol. 2005. PMID: 16239232 No abstract available.
Management of stage I and II ovarian carcinoma.
Thigpen JT, Lambuth BW, Vance RB. Thigpen JT, et al. Semin Oncol. 1991 Dec;18(6):596-602. Semin Oncol. 1991. PMID: 1775976 Review. No abstract available.
Patient-reported outcomes: clinical trials in ovarian cancer.
Carey MS, Gotay C; Gynecologic Cancer InterGroup (GCIG). Carey MS, et al. Int J Gynecol Cancer. 2011 May;21(4):782-7. doi: 10.1097/IGC.0b013e31821bb8be. Int J Gynecol Cancer. 2011. PMID: 21543941 Review. No abstract available.
Specific keynote: clinical trial design problems in ovarian cancer.
Stevenson A, Gore M. Stevenson A, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S117-21; discussion S122-3. doi: 10.1006/gyno.2002.6698. Gynecol Oncol. 2003. PMID: 12586100 Review. No abstract available.

See all similar articles

Cited by

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.
Herzog TJ, Armstrong DK, Brady MF, Coleman RL, Einstein MH, Monk BJ, Mannel RS, Thigpen JT, Umpierre SA, Villella JA, Alvarez RD. Herzog TJ, et al. Gynecol Oncol. 2014 Jan;132(1):8-17. doi: 10.1016/j.ygyno.2013.11.008. Epub 2013 Nov 15. Gynecol Oncol. 2014. PMID: 24239753 Free PMC article.
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
Pecorelli S, Ray-Coquard I, Tredan O, Colombo N, Parma G, Tisi G, Katsaròs D, Lhommé C, Lissoni AA, Vermorken JB, du Bois A, Poveda A, Frigerio L, Barbieri P, Carminati P, Brienza S, Guastalla JP. Pecorelli S, et al. Ann Oncol. 2010 Apr;21(4):759-765. doi: 10.1093/annonc/mdp514. Epub 2009 Nov 11. Ann Oncol. 2010. PMID: 19906760 Free PMC article. Clinical Trial.
Stratified randomization for platform trials with differing experimental arm eligibility.
Selukar S, May S, Law D, Othus M. Selukar S, et al. Clin Trials. 2021 Oct;18(5):562-569. doi: 10.1177/17407745211028872. Epub 2021 Aug 21. Clin Trials. 2021. PMID: 34420417 Free PMC article.
CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review.
Colloca G, Venturino A, Governato I. Colloca G, et al. Clin Transl Oncol. 2016 Aug;18(8):813-24. doi: 10.1007/s12094-015-1441-5. Epub 2015 Nov 6. Clin Transl Oncol. 2016. PMID: 26546024
Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology.
Sherrill B, Kaye JA, Sandin R, Cappelleri JC, Chen C. Sherrill B, et al. Onco Targets Ther. 2012;5:287-96. doi: 10.2147/OTT.S36683. Epub 2012 Oct 23. Onco Targets Ther. 2012. PMID: 23109809 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information